HRA Pharma Breaks Into US Consumer Health Market With Mederma Acquisition
Executive Summary
EllaOne and Compeed manufacturer HRA Pharma is set to establish a notable presence in the US consumer health market by acquiring the Mederma dermatology range from Germany's Merz.
You may also be interested in...
Building A Top-10 Global OTC Player – Q&A With HRA Pharma CEO David Wright
Exclusive: HBW Insight speaks to HRA Pharma CEO David Wright about the company's plans to become a top-10 global OTC player. Wright reveals that HRA is about to enter Latin America, beginning with Mexico and Brazil, and is currently looking at at least two significant acquisitions to ramp up its expansion plans in the coming months.
South Africa Next As HRA Pharma Marches On With Global Expansion
HRA Pharma brings Compeed to South Africa, moving the company one step closer to achieving its goal of becoming a top-10 global consumer healthcare player.
HRA Pharma Taking On China With JV Partner
HRA is putting feet on the ground in China as it looks to establish itself in the world second-largest consumer health market.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
